NCT00341380
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
Clinical trial condition
Carcinoma, Bronchogenic
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
5,258 public trials
1,193 recruiting studies
Carcinoma, Bronchogenic trial results
NCT02031458
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Angeles Clinic & Rsch Inst Los Angeles, California, United States
Completed
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
NCT01880528
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT00290355
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Edegem, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Leuven, Belgium
NCT00200395
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Beth Israel Medical Center New York, United States
- New York University New York, United States
- Albert Einstein Cancer Center The Bronx, New York, United States
- Montefiore Medical Center- The Bronx, New York, United States
NCT03811652
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +37 more
- Locations
-
- Research Site Huntersville, North Carolina, United States
- Research Site Nashville, Tennessee, United States
- Research Site Toronto, Ontario, Canada
Completed
A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
NCT00978250
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +21 more
- Locations
-
- University of California, Davis Davis, California, United States
- City of Hope National Medical Center Duarte, California, United States
- City of Hope Medical Group South Pasadena, California, United States
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02047344
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- UCSF San Francisco, California, United States
- Rush University Medical Center Chicago, Illinois, United States
- John Hopkins University Baltimore, Maryland, United States
NCT01813734
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- University of California, Irvine Orange, California, United States
- University of Maryland Baltimore, Maryland, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
Completed
A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT01667562
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Clinic for Pulmonology, Clinical Center of Serbia Belgrade, Serbia
- Clinical Center Bezanijska Kosa; Oncology Belgrade, Serbia
- Institute for pulmonary diseases of Vojvodina Kamenitz, Serbia
- Clinical Center Nis; Clinic for pulmonary diseases Knez Selo Niš, Serbia